Prescription Drug Diversion and Counterfeiting: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, First-[second] Session, Volume 4
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
U.S. Government Printing Office, 1986 - Drug control
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
activity adulterated Allen allowed American Association believe Bilirakis Board called Chairman committee companies concern consumers continuing correct cost counterfeit criminal Customs deal dispensing distribution drug diversion effective enforcement exper fact Federal Florida going hearings Helterhoff hospitals important indicated institutions internal invoice involved issue Kowitt license look manager manufacturers medication merchandise Miami Michigan nonprofit obtain Okay operation packaging Panama patient pharmaceuticals pharmacists pharmacy physicians pills practice prescription drugs problem profit purchase quantities question received record regulations representatives retail samples sell shipped Sikorski sold statement stored subcommittee talking Thank thing tion United wholesalers Wyden Yeah Yes Yes Yes Yes Yes